Peran Harapan dalam Kepatuhan Pengobatan Kanker Kolorektal

M. Agung Rahmadi; Helsa Nasution; Luthfiah Mawa; Romaito Nasution; Milna Sari

doi:10.61132/obat.v2i6.793

Authors

M. Agung Rahmadi Universitas Islam Negeri Syarif Hidayatullah Jakarta
Helsa Nasution Universitas Negeri Padang
Luthfiah Mawa Universitas Sumatera Utara
Romaito Nasution Universitas Islam Negeri Sumatera Utara
Milna Sari Universitas Islam Negeri Sumatera Utara

DOI:

https://doi.org/10.61132/obat.v2i6.793

Keywords:

hope, medication adherence, colorectal cancer

Abstract

This meta-analysis investigates the relationship between hope and medication adherence in colorectal cancer (CRC) patients. Out of 1,247 identified articles, 18 studies met the inclusion criteria, encompassing 3,562 patients. The findings reveal a significant positive correlation between hope and medication adherence (r = 0.42, 95% CI: 0.35-0.49, p < 0.001), with notable heterogeneity (I² = 76.4%, Q = 72.03, df = 17, p < 0.001). Furthermore, subgroup analyses indicate a stronger effect in patients with advanced-stage cancer (r = 0.49, 95% CI: 0.39-0.58) compared to those in various earlier stages (r = 0.38, 95% CI: 0.30-0.46, Q = 4.12, df = 1, p = 0.04). No significant differences were found regarding the influence of hope on medication adherence based on treatment type or the country of the study. Additionally, this research extends the findings of DiMatteo et al. (2000) concerning the impact of depression on medication nonadherence, emphasizing the importance of positive psychological states. Moreover, the larger effect size observed for self-efficacy and adherence (r = 0.31) reported by Hall et al. (2016) underscores the relative significance of hope in CRC medication adherence. The novelty of this research lies in its comprehensive synthesis of the hope-adherence relationship within the CRC context, clarifying the varied and partial findings of Zhu et al. (2017) and García-Torres et al. (2016). Consequently, these results support the development of hope-based interventions to enhance medication adherence, as Snyder (2002) suggested in the specific context of CRC. Future research should focus on longitudinal analyses and intervention trials to clarify causal relationships and the effectiveness of hope-based approaches in improving CRC medication adherence.

Downloads

Download data is not yet available.

References

Snyder, C. R. (2002). Hope theory: Rainbows in the mind. Psychological Inquiry, 13(4), 249-275.

DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Archives of internal medicine, 160(14), 2101–2107.

Folkman, S. (2012). Stress, coping, and hope. In Psychological aspects of cancer (pp. 119–127). Boston, MA: Springer US.

Hall, D. L., Luberto, C. M., Philpotts, L. L., Song, R., Park, E. R., & Yeh, G. Y. (2018). Mind‐body interventions for fear of cancer recurrence: a systematic review and meta‐analysis. Psycho‐oncology, 27(11), 2546–2558.

Zhu, L., Ranchor, A. V., Van Der Lee, M., Garssen, B., Sanderman, R., & Schroevers, M. J. (2015). The role of goal adjustment in symptoms of depression, anxiety and fatigue in cancer patients receiving psychosocial care: A longitudinal study. Psychology & Health, 30(3), 268-283.

Snyder, C. R., Harris, C., Anderson, J. R., Holleran, S. A., Irving, L. M., Sigmon, S. T., ... & Harney, P. (1991). The will and the ways: development and validation of an individual-differences measure of hope. Journal of personality and social psychology, 60(4), 570.

Carver, C. S., & Scheier, M. F. (2014). Dispositional optimism. Trends in cognitive sciences, 18(6), 293-299.

Rajandram, R. K., Ho, S. M., Samman, N., Chan, N., McGrath, C., & Zwahlen, R. A. (2011). Interaction of hope and optimism with anxiety and depression in a specific group of cancer survivors: a preliminary study. BMC research notes, 4, 1-7.

Mack, J. W., Fasciano, K. M., & Block, S. D. (2018). Communication about prognosis with adolescent and young adult patients with cancer: information needs, prognostic awareness, and outcomes of disclosure. Journal of Clinical Oncology, 36(18), 1861-1867.

Arrieta, Ó., Angulo, L. P., Núñez-Valencia, C., Dorantes-Gallareta, Y., Macedo, E. O., Martínez-López, D., ... & Oñate-Ocaña, L. F. (2013). Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Annals of surgical oncology, 20, 1941-1948.

Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A cancer journal for clinicians, 71(3), 209-249.

Arnold, M., Sierra, M. S., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2017). Global patterns and trends in colorectal cancer incidence and mortality. Gut, 66(4), 683–691.

World Health Organization. (2003). Adherence to long-term therapies: evidence for action. World Health Organization.

Greer, J. A., Amoyal, N., Nisotel, L., Fishbein, J. N., MacDonald, J., Stagl, J., ... & Pirl, W. F. (2016). A systematic review of adherence to oral antineoplastic therapies. The oncologist, 21(3), 354–376.

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., ... & Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372.

Alarcon, G. M., Bowling, N. A., & Khazon, S. (2013). Great expectations: A meta-analytic examination of optimism and hope. Personality and individual differences, 54(7), 821-827.

Takahashi, S., Matsumoto, K., Ohba, K., Nakano, Y., Miyazawa, Y., & Kawaguchi, T. (2023). The incidence and management of cancer-related anorexia during treatment with vascular endothelial growth factor receptor-tyrosine kinase inhibitors. Cancer Management and Research, 1033-1046.

Hall, A. E., Sanson-Fisher, R. W., Lynagh, M. C., Tzelepis, F., & D’Este, C. (2015). What do haematological cancer survivors want help with? A cross-sectional investigation of unmet supportive care needs. BMC research notes, 8, 1-6.

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A cancer journal for clinicians, 68(6), 394-424.

Stanton, A. L., Rowland, J. H., & Ganz, P. A. (2015). Life after diagnosis and treatment of cancer in adulthood: contributions from psychosocial oncology research. American Psychologist, 70(2), 159.

Krebber, A. M. H., Buffart, L. M., Kleijn, G., Riepma, I. C., De Bree, R., Leemans, C. R., ... & Verdonck‐de Leeuw, I. (2014). Prevalence of depression in cancer patients: a meta‐analysis of diagnostic interviews and self‐report instruments. Psycho‐Oncology, 23(2), 121-130.

Butow, P. N., Turner, J., Gilchrist, J., Sharpe, L., Smith, A. B., Fardell, J. E., ... & Thewes, B. (2017). Randomized trial of ConquerFear: a novel, theoretically based psychosocial intervention for fear of cancer recurrence. Journal of Clinical Oncology, 35(36), 4066-4077.